Predictors for cognitive decline in patients with confluent white matter hyperintensities

Alzheimer's and Dementia

Volumn 8, Issue SUPPL. 5, 2012, Pages

  Mok, Vincent ^a   Xiong, Yunyun ^a   Wong, Kelvin K ^b   Wong, Adrian ^a   Schmidt, Reinhold ^c   Chu, Winnie W C ^a   Hu, Xintao ^b   Lung Leung, Eric Yim ^d   Chen, Sirong ^d   Chen, Yangkun ^a   Tang, Wai Kwong ^a   Chen, Xiangyan ^a   Ho, Chi Lai ^d   Wong, Ka Sing ^a   Wong, Stephen T C ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

Author keywords

Alzheimer's disease; Cognitive decline; PiB; Stroke; White matter hyperintensities

Indexed keywords

APOLIPOPROTEIN E; PITTSBURGH COMPOUND B; VITAMIN B GROUP;

AGED; ARTICLE; BRAIN ATROPHY; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN SIZE; CLINICAL DEMENTIA RATING SCALE; CLINICAL FEATURE; COGNITIVE DEFECT; CORRELATION ANALYSIS; CORTICAL GRAY MATTER; DEMENTIA; FEMALE; FOLLOW UP; GRAY MATTER; HIPPOCAMPUS; HUMAN; HYPERLIPIDEMIA; LATERAL BRAIN VENTRICLE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MATTIS DEMENTIA RATING SCALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; STROKE; WHITE MATTER HYPERINTENSITY; WHITE MATTER LESION;

AGED; ATROPHY; BRAIN; COGNITION DISORDERS; DOUBLE-BLIND METHOD; FEMALE; FOLIC ACID; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NERVE FIBERS, MYELINATED; RECURRENCE; STROKE; VITAMIN B 12; VITAMIN B 6; VITAMIN B COMPLEX;

EID: 84866735040     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2011.10.004     Document Type: Article

References (36)

1. J.H. Fu, C.Z. Lu, Z. Hong, Q. Dong, Y. Luo, and K.S. Wong Extent of white matter lesions is related to acute subcortical infarcts and predicts further stroke risk in patients with first ever ischaemic stroke J Neurol Neurosurg Psychiatry 76 2005 793 796 (Pubitemid 40805808)
2. J. Jimenez-Conde, A. Biffi, R. Rahman, A. Kanakis, C. Butler, and S. Sonni Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke Stroke 41 2010 437 442
3. C. Dufouil, O. Godin, J. Chalmers, O. Coskun, S. MacMahon, and N. Tzourio-Mazoyer Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history Stroke 40 2009 2219 2221
4. R. Schmidt, P. Scheltens, T. Erkinjuntti, L. Pantoni, H.S. Markus, A. Wallin, F. Barkhof, and F. Fazekas White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease Neurology 63 2004 139 144 (Pubitemid 38943791)
5. G. Fein, C. Van Dyke, L. Davenport, B. Turetsky, M. Brant-Zawadzki, L. Zatz, W. Dillon, and P. Valk Preservation of normal cognitive functioning in elderly subjects with extensive white-matter lesions of long duration Arch Gen Psychiatry 47 1990 220 223 (Pubitemid 20086673)
6. V. Mok, E.Y. Leung, W. Chu, S. Chen, A. Wong, Y. Xiong, W. Lam, C.L. Ho, and K.S. Wong Pittsburgh compound B binding in poststroke dementia J Neurol Sci 290 2010 135 137
7. VITATOPS Trial Study Group B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial Lancet Neurol 9 2010 855 865
8. L.O. Wahlund, F. Barkhof, F. Fazekas, L. Bronge, M. Augustin, and M. Sjögren A new rating scale for age-related white matter changes applicable to MRI and CT Stroke 32 2001 1318 1322 (Pubitemid 32530416)
9. H.P. Adams Jr., B.H. Bendixen, L.J. Kappelle, J. Biller, B.B. Love, D.L. Gordon, and E.E. Marsh 3rd Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment Stroke 24 1993 35 41 (Pubitemid 23014379)
10. J.C. Morris The Clinical Dementia Rating (CDR): current version and scoring rules Neurology 43 1993 2412 2414 (Pubitemid 23346995)
11. H.F.K. Chiu, H.C. Kee, W.S. Chung, and P.K. Kwong Reliability and validity of the Cantonese version of Mini-mental state examination - a preliminary study J Hong Kong Coll Psychiatry 4 1994 25 28
12. A.S. Chan, M.K. Choi, and D.P. Salmon The effects of age, education, and gender on the Mattis Dementia Rating Scale performance of elderly Chinese and American individuals J Gerontol B Psychol Sci Soc Sci 56 2001 P356 P363
13. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th ed. 1994 APA Washington, DC
14. D. Shen, and C. Davatzikos Very high-resolution morphometry using mass-preserving deformations and HAMMER elastic registration Neuroimage 18 2003 28 41 (Pubitemid 36062745)
15. V.K. Srikanth, S.J. Quinn, G.A. Donnan, M.M. Saling, and A.G. Thrift Long-term cognitive transitions, rates of cognitive change, and predictors of incident dementia in a population-based first-ever stroke cohort Stroke 37 2006 2479 2483 (Pubitemid 44454664)
16. K. Narasimhalu, S. Ang, D.A. De Silva, M.C. Wong, H.M. Chang, K.S. Chia, A.P. Auchus, and C. Chen Severity of CIND and MCI predict incidence of dementia in an ischemic stroke cohort Neurology 73 2009 1866 1872
17. S. Miyao, A. Takano, J. Teramoto, and A. Takahashi Leukoaraiosis in relation to prognosis for patients with lacunar infarction Stroke 23 1992 1434 1438
18. D. Mungas, B.R. Reed, W.J. Jagust, C. DeCarli, W.J. Mack, J.H. Kramer, M.W. Weiner, N. Schuff, and H.C. Chui Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease Neurology 59 2002 867 873
19. N.D. Prins, E.J. van Dijk, T. den Heijer, S.E. Vermeer, J. Jolles, P.J. Koudstaal, A. Hofman, and M.M. Breteler Cerebral small-vessel disease and decline in information processing speed, executive function and memory Brain 128 2005 2034 2041 (Pubitemid 41253271)
20. W. Wen, P.S. Sachdev, X. Chen, and K. Anstey Gray matter reduction is correlated with white matter hyperintensity volume: a voxel-based morphometric study in a large epidemiological sample Neuroimage 29 2006 1031 1039 (Pubitemid 43184167)
21. D. Mungas, W.J. Jagust, B.R. Reed, J.H. Kramer, M.W. Weiner, and N. Schuff MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease Neurology 57 2001 2229 2235 (Pubitemid 34016456)
22. R. Schmidt, S. Ropele, C. Enzinger, K. Petrovic, S. Smith, H. Schmidt, P.M. Matthews, and F. Fazekas White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study Ann Neurol 58 2005 610 616 (Pubitemid 41377225)
23. P. Amarenco, J. Bogousslavsky, A. Callahan 3rd, L.B. Goldstein, M. Hennerici, and A.E. Rudolph High-dose atorvastatin after stroke or transient ischemic attack N Engl J Med 355 2006 549 559 (Pubitemid 44202151)
24. U. Khan, L. Porteous, A. Hassan, and H.S. Markus Risk factor profile of cerebral small vessel disease and its subtypes J Neurol Neurosurg Psychiatry 78 2007 702 706 (Pubitemid 46998839)
25. R. Schmidt, M. Hayn, F. Fazekas, P. Kapeller, and H. Esterbauer Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals. Correlations with plasma concentrations of naturally occurring antioxidants Stroke 27 1996 2043 2047 (Pubitemid 26372578)
26. W.T. Longstreth Jr., A.M. Arnold, N.J. Beauchamp Jr., T.A. Manolio, D. Lefkowitz, C. Jungreis, C.H. Hirsch, D.H. O'Leary, and C.D. Furberg Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study Stroke 36 2005 56 61 (Pubitemid 40054175)
27. D. Woo, B.M. Kissela, J.C. Khoury, L.R. Sauerbeck, M.A. Haverbusch, and J.P. Szaflarski Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage: a case-control study Stroke 35 2004 1360 1364
28. M. Giroud, E. Creisson, H. Fayolle, N. André, F. Becker, D. Martin, and R. Dumas Risk factors for primary cerebral hemorrhage: a population-based study - the Stroke Registry of Dijon Neuroepidemiology 14 1995 20 26
29. M.M. Mielke, P.P. Zandi, H. Shao, M. Waern, S. Östling, and X. Guo The 32-year relationship between cholesterol and dementia from midlife to late life Neurology 75 2010 1888 1895
30. R. Stewart, L.R. White, Q.L. Xue, and L.J. Launer Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study Arch Neurol 64 2007 103 107 (Pubitemid 46072431)
31. E.J. van Dijk, N.D. Prins, H.A. Vrooman, A. Hofman, P.J. Koudstaal, and M.M. Breteler Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study Stroke 39 2008 2712 2719
32. J. Verghese, R.B. Lipton, C.B. Hall, G. Kuslansky, and M.J. Katz Low blood pressure and the risk of dementia in very old individuals Neurology 61 2003 1667 1672 (Pubitemid 38020809)
33. J. De Reuck, D. Decoo, M.C. Hasenbroekx, B. Lamont, P. Santens, P. Goethals, K. Strijckmans, and I. Lemahieu Acetazolamide vasoreactivity in vascular dementia: a positron emission tomographic study Eur Neurol 41 1999 31 36 (Pubitemid 29043109)
34. R. Stewart, Q.L. Xue, K. Masaki, H. Petrovitch, G.W. Ross, L.R. White, and L.J. Launer Change in blood pressure and incident dementia: a 32-year prospective study Hypertension 54 2009 233 240
35. J.H. Lee, S.H. Kim, G.H. Kim, S.W. Seo, H.K. Park, S.J. Oh, J.S. Kim, H.K. Cheong, and D.L. Na Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B Neurology 77 2011 18 25
36. A. Nitkunan, T.R. Barrick, R.A. Charlton, C.A. Clark, and H.S. Markus Multimodal MRI in cerebral small vessel disease: its relationship with cognition and sensitivity to change over time Stroke 39 2008 1999 2005